Recombinant expression and purification method for anti-tumor active protein derived from pholiota nameko

A technology with anti-tumor activity and light cap, which is applied in the field of recombinant expression and purification of anti-tumor active protein, can solve the problems of low yield of anti-tumor active protein and unsuitability for industrial production, and achieve simple preparation process, low production cost, The effect of high yield

CN107828813AInactive Publication Date: 2018-03-23TIANJIN AGRICULTURE COLLEGE
5 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2018-03-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses a recombinant expression and purification method of an anti-tumor active protein derived from Umbrella photicum. The nucleotide sequence of the anti-tumor active protein gene of the present invention is shown in SEQ ID NO 1, and the amino acid sequence of the encoded protein is shown in SEQ ID NO 2. The anti-tumor active protein gene of the present invention was cloned into the prokaryotic expression vector pET-MBP to construct the recombinant plasmid pET-MBP-PNAP, transformed into Escherichia coli BL21 (DE3), and induced by isopropylthiogalactoside (IPTG) to express the fusion protein His ‑MBP‑PNAP, using tobacco etch virus (TEV) protease to remove the His‑MBP tag, and then purified by maltose affinity chromatography and gel filtration chromatography to obtain recombinant protein PNAP. Compared with the natural anti-tumor active protein derived from Umbrella glabra, the recombinant protein PNAP of the present invention has stronger anti-proliferation activity on breast cancer MCF7 cells, and has simple preparation process, low production cost and high yield, and is suitable for industrial production .
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a recombinant expression and purification method of an anti-tumor active protein derived from Umbrella glabra. Background technique

[0002] Light cap scale umbrella, commonly known as sliding mushroom, is named for its cap and stipe surface with a layer of mucus, which is slippery and delicious when eaten. Slide mushrooms are not only rich in protein, amino acids, carbohydrates and other nutrients, but also contain a variety of vitamins, as well as calcium, phosphorus, iron and other trace elements, which can improve the body's immunity, enhance intelligence, improve endurance, and have broad development prospects.

[0003] Domestic researchers have conducted a lot of research on Pleurotus ostreatus, involving mycelium biological characteristics, submerged culture and cultivation techniques, determination and analysis of nutritional components, etc. At present, the rese...

Examples

Embodiment 1

[0019] Example 1 The extraction of the total RNA of the umbrella phobia

[0020] (1) Take fresh Umbrella glabra, wash and cut it into pieces, and grind it directly in Trizol, using 1mL Trizol for every 100mg;

[0021] (2) Place the homogenized sample at 20°C for 5 minutes, centrifuge at 12000rpm at 4°C for 10 minutes, and take the supernatant;

[0022] (3) Add 0.2mL chloroform for every 1mL Trizol used, shake vigorously for 30sec, and place at 10°C for 5min;

[0023] (4) Centrifuge at 4°C, 12000rpm for 10min, and transfer the aqueous phase to a new centrifuge tube;

[0024] (5) Add 500 μl of isopropanol and place at 20°C for 30 minutes;

[0025] (6) Centrifuge at 4°C, 12000rpm for 10min, discard the supernatant;

[0026] (7) Add 1.0mL 75% ethanol to wash the precipitate;

[0027] (8) Centrifuge at 4°C, 5000rpm for 5min, pour off the liquid;

[0028] (9) Leave to dry at room temperature, add 50 μl RNase-Free ddH 2 O, fully dissolve the RNA.

Embodiment 2

[0029] Example 2 Reverse transcription PCR to obtain genes

[0030] (1) Reverse transcription to synthesize the first strand of cDNA

[0031] PCR reaction solution: total RNA 0.5μl, 5×RT MasterMix 4μl, *Oligo(dT) primer 1μl, H 2 Make up O to 20 μl; PCR program: 42°C for 1h, 95°C for 5min;

[0032] (2) Degenerate primers F: 5'-TACTTCCAATCCAATGCYGGNAGNACNTTYATHGGNTAYAAYGGN-3' and R: 5'-TTATCCACTTCCAATGCTANCGRACCCANGAYTTCATNAGRAAYTCYTT-3' were synthesized according to the determined N-terminal amino acid sequence AGRTFIGYNG and C-terminal amino acid sequence KEFLMKSWVR of the anti-tumor active protein gene, where R= A+G, Y=T+C, H=A+C+T, N=T+C+A+G;

[0033] (3) Amplify the first strand of cDNA by polymerase chain reaction

[0034] PCR reaction solution: Tag Plus Polymerase Buffer 5μl, dNTP Mix 3μl, F 2μl, R 2μl, cDNA 0.2μl, Tag Plus Polymerase 1μl, H 2 O was added to 50 μl; PCR program: 94°C 5min; 94°C 40s, 55°C 40s, 72°C 60s, 30 cycles; 72°C 10min.

Embodiment 3

[0035] Example 3 Construction of fusion expression vector pET-MBP-PNAP

[0036] (1) SspI single enzyme digestion treatment of vector pET-MBP

[0037] Enzyme digestion reaction system: 17 μl of carrier, 1 μl of SspI, 2 μl of SspI buffer; digestion at 37°C for 3 hours. 1% agarose gel electrophoresis identification, recovery of the target band.

[0038] (2) T4 polymerase treatment and ligation of vector SspI single-digestion product and PCR product

[0039] The T4 reaction system of the carrier SspI single-digestion product: 15 μl of carrier, 2 μl of T4 polymerase buffer, 0.5 μl of T4 polymerase, 1 μl of dGTP, 1 μl of DTT, 0.5 μl of BSA; reaction conditions: 22°C for 30 minutes; 75°C for 20 minutes.

[0040] T4 reaction system for PCR products: PCR product 15 μl, T4 polymerase buffer 2 μl, T4 polymerase 0.5 μl, dCTP 1 μl, DTT 1 μl, BSA 0.5 μl; reaction conditions: 22°C 30min; 75°C 20min.

[0041] Mix 1 μl of T4 polymerase-treated vector with 9 μl of PCR product, connect at 22°...